Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lerut

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 9, 2024
Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?Jan Lerut
Transplant International : Official Journal of the European Society for Organ Transplantation|September 9, 2014
Professor Gilles Mentha (1952-2014)Jan Lerut
Translational Gastroenterology and Hepatology|November 24, 2017
Hepatocellualr cancer and liver transplantation: from the tower of babel towards a uniform languageProf Jan Lerut
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 2014
Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'Quirino Lai, Jan Lerut
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 6, 2015
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantationQuirino Lai, Jan Lerut,
Transplant International : Official Journal of the European Society for Organ Transplantation|November 17, 2022
A Western World Perspective of Survival Benefit of Living Donor Liver Transplantation: A Commentary to the Article by Jackson et al. Published in JAMA SurgeryQuirino Lai, Jan Lerut
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 15, 2015
Morphology does not tell us the entire story: biological behavior improves our ability to select patients with hepatocellular carcinoma waiting for liver transplantationJan Lerut, Quirino Lai
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 26, 2014
α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theoryQuirino Lai, Jan Lerut,
Transplantation|January 27, 2023
Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular CarcinomaJan Lerut, Quirino Lai
Transplant International : Official Journal of the European Society for Organ Transplantation|July 14, 2010
Liver transplantation for malignancies. How did we get there?Jan Lerut, Gilles Mentha
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 9, 2024
Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?Jan Lerut
Transplant International : Official Journal of the European Society for Organ Transplantation|September 9, 2014
Professor Gilles Mentha (1952-2014)Jan Lerut
Translational Gastroenterology and Hepatology|November 24, 2017
Hepatocellualr cancer and liver transplantation: from the tower of babel towards a uniform languageProf Jan Lerut
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 2014
Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'Quirino Lai, Jan Lerut
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 6, 2015
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantationQuirino Lai, Jan Lerut,
Transplant International : Official Journal of the European Society for Organ Transplantation|November 17, 2022
A Western World Perspective of Survival Benefit of Living Donor Liver Transplantation: A Commentary to the Article by Jackson et al. Published in JAMA SurgeryQuirino Lai, Jan Lerut
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 15, 2015
Morphology does not tell us the entire story: biological behavior improves our ability to select patients with hepatocellular carcinoma waiting for liver transplantationJan Lerut, Quirino Lai
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 26, 2014
α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theoryQuirino Lai, Jan Lerut,
Transplantation|January 27, 2023
Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular CarcinomaJan Lerut, Quirino Lai
Transplant International : Official Journal of the European Society for Organ Transplantation|July 14, 2010
Liver transplantation for malignancies. How did we get there?Jan Lerut, Gilles Mentha
Pageof 20